(Q34561521)

3 August 2017

1 reference

title

Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy (English)

1 reference

3 August 2017

0 references

angiogenesis inhibitor

1 reference

Judith H Harmey

1

1 reference

3 August 2017

David Bouchier-Hayes

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

24

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

280-283

1 reference

Tumor angiogenesis: therapeutic implications

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10043

21 January 2018

Identifiers

DOI

10.1002/BIES.10043

1 reference

3 August 2017

1 reference